Search USAQ
QHSLab, Inc.
OTC · CIK 856984
Last close0.32
Daily change+0.00 (0.00%)
10 Years gain+190.91%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
USAQ · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
68.6Momentum
32.0Acceleration
32.0Confidence
67.0Annual Revenue12
Quarterly Revenue38
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth19.0 / 25
Quality19.8 / 25
Capital Efficiency16.7 / 20
Balance Sheet9.6 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.9771 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 3.5976 percentage points.
Heavy share dilution · HIGHDiluted share count increased 106.2066%.
Low interest coverage · HIGHInterest coverage is 0.4071x.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM35.67%OK
Revenue CAGR 3Y29.37%OK
Gross Margin66.92%OK
Operating Margin2.01%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC14.25%OK
Incremental Operating Margin 3Y40.97%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y106.21%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.69M | $1.81M | $131,244.00 | n/a | n/a | 67.27% | 4.88% | n/a | 24.11% | 19.34M |
| 2025 FY Dec 31, 2024 | $2.13M | $1.36M | $205,738.00 | $142,437.00 | n/a | 63.69% | 9.65% | n/a | n/a | 10.29M |
| 2024 FY Dec 31, 2023 | $1.41M | $793,607.00 | -$240,158.00 | -$159,627.00 | n/a | 56.32% | -17.04% | n/a | -105.76% | 9.42M |
| 2023 FY Dec 31, 2022 | $1.24M | $619,519.00 | -$560,539.00 | -$350,994.00 | n/a | 49.83% | -45.09% | n/a | -85.9% | 9M |
| 2022 FY Dec 31, 2021 | $1.41M | $670,748.00 | -$502,258.00 | -$354,738.00 | n/a | 47.42% | -35.51% | n/a | -897.62% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.92M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-037255, 0001493152-25-022138 |
| Revenue Growth TTM | 35.67% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-037255, 0001493152-25-022138 |
| Revenue CAGR 3Y | 29.37% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-013513 |
| Revenue CAGR 5Y | 84.91% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-013513 |
| Gross Profit CAGR 3Y | 42.98% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-013513 |
| Operating Income Growth | -51.38% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001493152-26-037255, 0001493152-25-022138 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 66.92% | Gross Profit / Revenue | OK | 0001493152-26-037255, 0001493152-25-022138 |
| Operating Margin | 2.01% | Operating Income / Revenue | OK | 0001493152-26-037255, 0001493152-25-022138 |
| ROIC | 14.25% | NOPAT / Average Invested Capital | OK | 0001493152-26-037255, 0001493152-25-022138 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-037255 |
| Interest Coverage | 0.41x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.82x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.13 | Revenue / Diluted Shares | OK | 0001493152-26-037255, 0001493152-25-022138 |